The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease

Neurological Research

Volumn 26, Issue 5, 2004, Pages 573-578

  Bailey, Thomasina L ^a   Rivara, Claire B ^a   Rocher, Anne B ^a   Hof, Patrick R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid angiopathy; Brain aging; Capillaries; Cerebral cortex; Cerebral microvasculature; Dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN CORTEX; BRAIN FUNCTION; CARDIOVASCULAR RISK; CELL LOSS; COGNITIVE DEFECT; DEMENTIA; HOMEOSTASIS; HUMAN; NERVE DEGENERATION; NEUROPATHOLOGY; PATHOGENESIS; PLAQUE FORMING CELL; VASCULAR AMYLOIDOSIS;

AGING; ALZHEIMER DISEASE; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; HUMANS; MICROCIRCULATION;

EID: 3042836549     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225016272     Document Type: Article

References (90)

1. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of AD in a community population of older persons higher than previously reported. J Am Med Assoc 1989; 262: 2551-2556
2. Fair JM. Cardiovascular risk factor modification: Is it effective in older adults? J Cardiovasc Nurs 2003; 3: 161-168
3. Bowler J, Hachinski V. History of the concept of vascular dementia: Two opposing views on current definitions and criteria for vascular dementia. In: Prohovnik I, Wade J, Knezevic S, et al., eds. Vascular Dementia. New York: John Wiley & Sons, 1996: pp. 1-28
4. Desmond DW. Vascular dementia: A construct in evolution. Cerebrovasc Brain Metab Rev 1996; 8: 296-325
5. Bowler JV. Criteria for vascular dementia: Replacing dogma with data Arch Neurol 2000; 57: 170-171
6. Skoog I, Nilsson L, Palmertz B, et al. A population based study of dementia in 85 year olds. N Engl J Med 1993; 328: 153-158
7. Kay DW, Dewey ME, McKeith IG, et al. Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes. Int J Geriatr Psychiatry 1998; 13: 852-862
8. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers [see comments]. Neurology 1992; 42: 473-480
9. Pohjasvaara T, Mantyla R, Ylikoski R, et al. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. Stroke 2000; 31: 2952-2957
10. Amar K, Wilcock GK, Scott M. The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996; 25: 51-55
11. Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996; 27: 30-36
12. Verhey F, Lodder J, Rozendaal N, et al. Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996; 15: 16-72
13. Giannakopoulos P, Hof PR, Mottier S et al. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: Retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol 1994; 87: 456-468
14. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease - A primer for practicing neuropathologists. Arch Pathol Lab Med 1993; 117: 132-144
15. Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science 1997; 278: 412-419
16. Morrison JH, Hof PR. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res 2002;136:467-486
17. Hof PR, Bussière T, Gold G, et al. Stereologic evidence for persistance of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer's disease. J Neuropathol Exp Neurol 2003;62:55-67
18. Bussière T, Gold G, Kövari E, et al. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience 2003; 117: 577-592
19. Bussière T, Giannakopoulos P, Bouras C, et al. Neurofilament protein-enriched pyramidal neurons are preferentially vulnerable to tangle formation in Alzheimer's disease: A stereologic analysis of area 9. J Comp Neurol 2003; 463: 281-302
20. Vickers JC, Delacourte A, Morrison JH. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res 1992; 594: 273-278
21. Vickers JC, Riederer BM, Marugg RA, et al. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 1994; 62: 1-13
22. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970; 11: 205-242
23. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974; 2: 207-210
24. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-637
25. Hachinski V, Muñoz D. Vascular factors in cognitive impairment - where are we now? Ann NY Acad Sci 2000; 903: 1-5
26. Aguero-Torres H, Winblad B. Alzheimer's disease and vascular dementia. Some points of confluence. Ann NY Acad Sci 2000; 903: 547-552
27. Xuereb JH, Brayne C, Dufouil C, et al. Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann NY Acad Sci 2000; 903: 490-496
28. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. J Am Med Assoc 1997; 277: 813-817
29. Shi J, Perry G, Smith MA, et al. Vascular abnormalities: The insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 2000; 21: 357-361
30. Gold G, Bouras C, Canuto A, et al. Clinicopathological validation study of four sets of clinical criteria for vascualr dementia. Am J Psychiatry 2002; 159: 82-87
31. Emery VO, Gillie EX, Smith JA. Interface between vascular dementia and Alzheimer syndrome. Nosologic redefinition. Ann NY Acad Sci 2000; 903: 229-238
32. Skoog I, Gustafson D. Hypertension and related factors in the etiology of Alzheimer's disease. Ann NY Acad Sci 2002; 977: 29-36
33. Stewart R. Cardiovascular factors in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998; 65: 143-147
34. Stewart R. Vascular dementia: A diagnosis running out of time. Br J Psychiatry 2002; 180: 152-156
35. Zekry D, Hauw JJ, Gold G. Mixed dementia: Epidemiology, diagnosis, and treatment. J Am Geriatr Soc 2002; 50: 1431-1438
36. Kivipelto M, Laakso MP, Tuomilehto J, et al. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: Potential for pharmacological intervention. CNS Drugs 2002; 16: 435-444
37. Slooter AJ, Houwing-Duistermaat JJ, van Harskamp F, et al. Apolipoprotein E genotype and progression of Alzheimer's disease: The Rotterdam Study. J Neurol 1999; 246: 304-308
38. Breteler MM, Bots ML, Ott A, et al. Risk factors for vascular disease and dementia. Haemostasis 1998; 28: 167-173
39. Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997; 42: 776-782
40. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-154
41. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arteriosclerosis Thromb Vasc Biol 2000;20:2255-2260
42. Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: The HAAS. Honolulu-Asia aging Study. Neurobiol Aging 2000; 21: 57-62
43. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002; 51: 1256-1262
44. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. Br Med J 2001; 322: 1447-1451
45. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001; 56: 1683-1689
46. Sparks DL, Scheff SW, Liu H, et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995; 131: 162-169
47. Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain β-amyloid, phopsphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 2003;60:29-35
48. Launer LJ, White LR, Petrovitch H, et al. Cholesterol and neuropathologic markers of AD: A population-based autopsy study. Neurology 2001; 57: 1447-1452
49. Lesser G, Kandiah K, Libow LS, et al. Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease. Dement Geriatr Cogn Dis 2001; 12: 138-145
50. Bell MA, Ball MJ. Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities. Acta Neuropathol 1981; 53: 299-318
51. Scheibel AB, Duong T, Tomiyasu U. Microvascular changes in AD. In: Scheibel AB, Wechsler AF, Brazier MAB, eds. The Biological Substrates of Alzheimer's Disease. UCLA Forum in Medical Sciences, Vol. 27. Orlando: Academic Press, 1986: pp. 177-192
52. Hassler O. Vascular changes in senile brains. Acta Neuropathol 1965;5:40-53
53. Ravens JR. Vascular changes in the human senile brain. Adv Neurol 1978; 20: 487-501
54. Fischer VW, Siddiqui A, Yusufaly Y. Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 1990;79:672-679
55. Buée L, Hof PR, Bouras C, et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994; 87: 469-480
56. Mann DMA, Eaves NR, Marcyniuk B, et al. Quantitative changes in cerebral cortical microvasculature in ageing and dementia. Neurobiol Aging 1986; 7: 321-330
57. Bell MA, Ball MJ. Neuritic plaques and vessels of visual cortex in aging and Alzheimer's dementia. Neurobiol Aging 1990; 11: 359-370
58. Batra S, König MF, Cruz-Orive LM. Unbiased estimation of capillary length from vertical slices. J Microsc 1995; 178: 152-159
59. Keuker JIH, Luiten PGM, Fuchs E. Capillary changes in hippocampal CA1 and CA3 areas of the aging rhesus monkey. Acta Neuropathol 2000; 100: 665-672
60. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259
61. Gazzaley AH, Thakker MM, Hof PR, et al. Preserved number of entorhinal cortex layer II neurons in aged macaque monkeys. Neurobiol Aging 1997; 18: 549-553
62. Peters A, Morrison JH, Rosene DL, et al. Are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex 1998; 8: 295-300
63. Hof PR, Nimchinsky EA, Young WG, et al. Numbers of Meynert and layer IVB cells in area VI: A stereologic analysis in young and aged macaque monkeys. J Comp Neurol 2000; 420: 113-126
64. Jicha GA, Lane E, Vincent I, et al. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filament of Alzheimer's disease. J Neurochem 1997; 69: 2087-209
65. Vincent I, Zheng JH, Dickson DW, et al. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging 1998; 19: 287-296
66. Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 1999; 58: 188-197
67. Dayan AD, Ball MJ. Histometric observations on the metabolism of tangle-bearing neurons. J Neurol Sci 1973; 19: 433-436
68. Bussière T, Friend PD, Sadeghi N, et al. Stereologic determination of the total cortical volume occupied by amyloid deposition and correlation with cognitive status in normal brain aging and Alzheimer's disease. Neuroscience 2002; 112: 75-91
69. Redwine JM, Kosofsky B, Jacobs RE, et al. The dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci USA 2003; 100: 1381-1386
70. Calhoun ME, Burgermeister P, Phinney AL, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999; 96: 14088-14093
71. Iwamoto N. "Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: Relationship to blood vessels." Acta Neuropathol 1997; 93: 334-340
72. Thal DR, Ghebremedhin E, Orantes M, et al. Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 2003; 62: 1287-1301
73. Vinter HV, Wang Z. Non-CAA angiopathies and their possible interactions with cerebral amyloid angiopathy. Amyloid 2001; 8: 2-9
74. van Horssen J, Wilhelmus MMM, Heljasvaara R, et al. Collagen XVIII: A novel heparan sulfate proteoglycan assocaited with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol 2002; 12: 456-462
75. Iwatsubo T, Saido TC, Mann DM, et al. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol 1996; 149: 1823-1830
76. Wisniewski HM. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 1994; 87: 233-241
77. Wisniewski HM, Wegiel J, Wang KC, et al. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992; 84: 117-127
78. Weller RO, Nicoll JA. Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 2003; 25: 611-616
79. Shi J, Perry G, Smith MA, Friedland RP. Vascular abnormalities: The indigenous pathogenesis of Alzheimer's disease. Neurobiol Aging 2000; 21: 377-361
80. Townsend KP, Obregon D, Quadros A, et al. Proinflammatory and vasoactive Effects of beta amyloid in the cerebrovasculature. Ann NY Acad Sci 2002; 977: 65-76
81. Paris D, Town T, Parker T, et al. Beta amyloid vasoactivity: An inflammatory reaction. Ann NY Acad Sci 2000; 903: 97-109
82. Paris D, Humphrey J, Quadros A, et al. Vasoactive effects of Aβ in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: Role of inflammation. Neurol Res 2003; 25: 642-651
83. Rensink AA, de Waal RM, Kremer B, et al. Pathogenesis of cerebral amyloid angiopathy. Brain Res Rev 2003; 43: 207-223
84. Jellinger, Alzheimer disease and cerebrovascular pathology - an update. J Neural Transm 2002; 109: 813-836
85. Tian J, Shi J, Bailey K, et al. Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease. Neurosci Lett 2003; 352: 137-140
86. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with AD: The CERAD experience, Part XV. Neurology 1996; 46: 1592-1596
87. Wu E, Lipton RB, Dickson DW. Amyloid angiopathy in diffuse Lewy body disease. Neurology 1992; 42: 2131-2135
88. Pfeifer LA, White LR, Ross GW, et al. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study. Neurology 2002; 58:1629-1634
89. Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - A pilot study. Acta Neuropathol 2004; 107: 83-90
90. Aliev G, Seyidova D, Lamb BT, et al. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol Res 2003; 25: 665-674